clinical trial · NCT00650533
Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
HealthyGlimepiride Tablets 1 mgAmaryl® Tablets 1 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's glimepiride 1 mg tablets to Aventis Amaryl® 1 mg tablets following a single, oral 1 mg (1 x 1 mg) dose administered under fed conditions.
started
Nov 1, 2004
primary completion
Dec 1, 2004
completion
Dec 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Glimepiride Tablets (1 mg; Mylan) to Amaryl® Tablets (1 mg; Aventis) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol